Cargando…
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
BACKGROUND: Chemokines can block viral entry by interfering with HIV co-receptors and are recognised mediators of atherosclerosis development. A number of experimental drugs that inhibit HIV entry arrest the development of atherosclerosis in animal models. We hypothesised that the expression of chem...
Autores principales: | Fernández-Sender, Laura, Alonso-Villaverde, Carlos, Rull, Anna, Rodríguez-Gallego, Esther, Riera-Borrull, Marta, Hernández-Aguilera, Anna, Camps, Jordi, Beltrán-Debón, Raúl, Aragonès, Gerard, Menendez, Javier A, Joven, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663662/ https://www.ncbi.nlm.nih.gov/pubmed/23659629 http://dx.doi.org/10.1186/1742-6405-10-11 |
Ejemplares similares
-
The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients
por: Aragonès, Gerard, et al.
Publicado: (2012) -
Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism
por: Aragonès, Gerard, et al.
Publicado: (2011) -
Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes
por: Alonso-Villaverde, Carlos, et al.
Publicado: (2009) -
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012) -
Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)